Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
Platform developed with CDSCO and NRCeS includes over 123,000 branded drugs an...
The FDA has requested further information, primarily focusing on the manufacturi...
This Jaypirca CHMP recommendation for CLL applies across all lines of therapy, r...
Deal values Pivot Path at ~₹2.3 billion post-money; Strides to realise ~₹1 bill...
Dapsone Gel is indicated for the topical treatment of acne vulgaris The post Al...
The initial phase of the partnership, valued at up to $15m and running until 202...
Ionis will retain the responsibility for commercialising the RNA-targeted medici...
The facility, to be located at the Board of Investment zone in Horana, will be ...
Expands Schedule H2 to include vaccines, antimicrobials and anticancer drugs Th...
Oseltamivir Phosphate is an influenza neuraminidase inhibitor (NAI) indicated f...
The unified platform enables users to check the prices of scheduled and non-sch...
The tentative approval covers the 40 mg, 80 mg, 120 mg, and 160 mg strengths Th...
The facility has received EU GMP certification from the Malta Medicines Authori...
The company informed that the facility which is fully operational, is designed ...
The authorisation applies to adults with resectable MIBC who cannot be treated w...
Frazier Life Sciences led the financing round along with new investors EQT Life ...
